Wall Street is positive on Graphite Bio Inc (GRPH). On average, analysts give Graphite Bio Inc a Hold rating. The average price target is $3, which means analysts expect the stock to decline by -0.33% over the next twelve months. That average ranking earns Graphite Bio Inc an Analyst Rating of 5, which is better than 5% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating GRPH a Hold today. Find out what this means to you and get the rest of the rankings on GRPH!